Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53

Oncogene volume 22, pages 5586–5591 (2003)Cite this article

Abstract

Dual-specificity phosphatase 5 (DUSP5), a VH1-like enzyme that hydrolyses nuclear substrates phosphorylated on both tyrosine and serine/threonine residues, has a potential role in deactivation of mitogen- or stress-activated protein kinases. Using cDNA-microarray technology, we found that the expression of DUSP5 mRNA was dramatically increased by exogenous p53 in U373MG, a p53-mutant glioblastoma cell line. Transcription of DUSP5 was also remarkably activated by endogenous p53 in response to DNA damage in colon-cancer cells (p53+/+) that contained wild-type p53, but not in p53−/− cells. Chromatin-immunoprecipitation (ChIP) and reporter assays demonstrated that endogenous p53 protein would bind directly to the promoter region of the DUSP5 gene, implying p53-dependent transcriptional activity. Overexpression of DUSP5 suppressed the growth of several types of human cancer cells, in which Erk1/2 was significantly dephosphorylated. If, as the results suggest, DUSP5 is a direct target of p53, it represents a novel mechanism by which p53 might negatively regulate cell-cycle progression by downregulating mitogen- or stress-activated protein kinases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Brondello JM, Pouyssegur J and McKenzie FR . (1999). Science, 286, 2514–2517.

  • el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B . (1992). Nat. Genet., 1, 45–49.

  • Furuhata T, Tokino T, Urano T and Nakamura Y . (1996). Oncogene, 13, 1965–1970.

  • Guan KL and Butch E . (1995). J. Biol. Chem., 270, 7197–7203.

  • Hollstein M, Sidransky D, Vogelstein B and Harris CC . (1991). Science, 253, 49–53.

  • Iiizumi M, Arakawa H, Mori T, Ando A and Nakamura Y . (2002). Cancer Res., 62, 1246–1250.

  • Ishibashi T, Bottaro DP, Michieli P, Kelley CA and Aaronson SA . (1994). J. Biol. Chem., 269, 29897–29902.

  • Kim TI, Jin SH, Kang EH, Shin SK, Choi KY and Kim WH . (2002). Ann. N. Y. Acad. Sci., 973, 241–245.

  • Ko LJ and Prives C . (1996). Genes Dev., 10, 1054–1072.

  • Kovanen PE, Rosenwald A, Fu J, Hurt EM, Lam LT, Giltnane JM, Wright G, Staudt LM and Leonard WJ . (2002). J. Biol. Chem., 278, 5205–5213.

  • Levine AJ . (1997). Cell, 88, 323–331.

  • Martell KJ, Kwak S, Hakes DJ, Dixon JE and Trent JM . (1994). Genomics, 22, 462–464.

  • Marti F, Krause A, Post NH, Lyddane C, Dupont B, Sadelain M and King PD . (2001). J. Immunol., 166, 197–206.

  • McGrory WJ, Bautista DS and Graham FL . (1988). Virology, 163, 614–617.

  • Miyashita T and Reed JC . (1995). Cell, 80, 293–299.

  • Mori T, Anazawa Y, Matsui K, Fukuda S, Nakamura Y and Arakawa H . (2002a). Neoplasia, 4, 268–274.

  • Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y and Arakawa H . (2002b). Oncogene, 21, 2914–2918.

  • Ng CC, Koyama K, Okamura S, Kondoh H, Takei Y and Nakamura Y . (1999). Genes Chromosomes Cancer, 26, 329–335.

  • Nishimori H, Shiratsuchi T, Urano T, Kimura Y, Kiyono K, Tatsumi K, Yoshida S, Ono M, Kuwano M, Nakamura Y and Tokino T . (1997). Oncogene, 15, 2145–2150.

  • Ochi K, Mori T, Toyama Y, Nakamura Y and Arakawa H . (2002). Neoplasia, 4, 82–87.

  • Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y and Taya Y . (2000). Cell, 102, 849–862.

  • Okamura S, Arakawa H, Tanaka T, Nakanishi H, Ng CC, Taya Y, Monden M and Nakamura Y . (2001). Mol. Cell, 8, 85–94.

  • Ono K, Tanaka T, Tsunoda T, Kitahara O, Kihara C, Okamoto A, Ochiai K, Takagi T and Nakamura Y . (2000). Cancer Res., 60, 5007–5011.

  • Oren M . (1994). Semin. Cancer Biol., 5, 221–227.

  • Shiraishi K, Fukuda S, Mori T, Matsuda K, Yamaguchi T, Tanikawa C, Ogawa M, Nakamura Y and Arakawa H . (2000). Cancer Res., 60, 3722–3726.

  • Stefanovsky VY, Pelletier G, Hannan R, Gagnon-Kugler T, Rothblum LI and Moss T . (2001). Mol. Cell, 8, 1063–1073.

  • Takei Y, Ishikawa S, Tokino T, Muto T and Nakamura Y . (1998). Genes Chromosomes Cancer, 23, 1–9.

  • Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y and Nakamura Y . (2000). Nature, 404, 42–49.

  • Tokino T, Thiagalingam S, el-Deiry WS, Waldman T, Kinzler K W and Vogelstein B . (1994). Hum. Mol. Genet., 3, 1537–1542.

  • Urano T, Nishimori H, Han H, Furuhata T, Kimura Y, Nakamura Y and Tokino T . (1997). Cancer Res., 57, 3281–3287.

  • Yoo J, Park SY, Robinson RA, Kang SJ, Ahn WS and Kang CS . (2002). Arch. Pathol. Lab. Med., 126, 1096–1100.

Download references

Author information

Author notes

  1. Hirofumi Arakawa

    Present address: Cancer Medicine and Biophysics Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan

Authors and Affiliations

  1. Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan

    Koji Ueda, Hirofumi Arakawa & Yusuke Nakamura

Authors
  1. Koji Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hirofumi Arakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yusuke Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yusuke Nakamura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ueda, K., Arakawa, H. & Nakamura, Y. Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53. Oncogene 22, 5586–5591 (2003). https://doi.org/10.1038/sj.onc.1206845

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206845

Keywords

This article is cited by

Search

Advanced search

Quick links